26 February 2017
News and Views
Links and Services
The latest issue of Gut evaluates the risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.
Professor Laurent Beaugerie and colleagues from France explored the risk of new
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors